ImmunoSource SRL
The score of ImmunoSource shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ImmunoSource's annual accounts
Filed annual accounts
- Year ended 31 Jul 2025filed on 10 Feb 2026
- Year ended 31 Jul 2024filed on 20 Feb 2025
- Year ended 31 Jul 2023filed on 28 Feb 2024
- Year ended 31 Jul 2022filed on 28 Feb 2023
- Year ended 31 Jul 2021filed on 11 Feb 2022
ImmunoSource's financial analysis
- Solvency98.2%sector median: 39.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ImmunoSource
ImmunoSource's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.125.125
- VAT number
- BE0451125125
- Peppol
- Registered · 0208:0451125125 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Oct 1993
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 10 Feb 2026
- Activity
- Other miscellaneous personal service activities (NACE 96999)
ImmunoSource (SRL) has been based in Schilde since 1993, active in: other miscellaneous personal service activities. For 2025, it reports a net profit of 92,739 € and equity of €1.40m; its revenue is not published. Its solvency stands at 98.2%, above the median of its sector (39.9%).
Companies similar to ImmunoSource
Companies in the same business, of comparable size and area, outside its group.
- I&DP Other information service activities Evergem · balance sheet €1.58m
- Comme Promis Other information service activities Heuvelland · balance sheet €1.12m
- Beebonds Finance Other financial service activities, except insurance and pension funding n.e.c. Auderghem · balance sheet €1.91m
- CvanCalsteren Other information service activities Turnhout · balance sheet €2.38m
- Kasparov Other information service activities Putte · balance sheet €2.42m
- PONT Other information service activities Bredene · balance sheet 810,229 €
- ID Farma Other financial service activities, except insurance and pension funding n.e.c. Zandhoven · balance sheet €1.56m
- Quantrix Capital Other financial service activities, except insurance and pension funding n.e.c. Brasschaat · balance sheet €1.62m
Frequently asked questions about ImmunoSource
What is the revenue of ImmunoSource?
ImmunoSource files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ImmunoSource?
In Belgium, the VAT number is the company number prefixed with BE: BE0451125125 for ImmunoSource, if the company is VAT-registered. Its company number (CBE) is 0451.125.125.
Where is the registered office of ImmunoSource?
According to the CBE register, the registered office of ImmunoSource is in 2970 Schilde.
What is the equity of ImmunoSource?
At the close of the 2025 financial year, the equity of ImmunoSource amounts to 1,398,557 €, a solvency of 98.2% of total assets.
Who manages ImmunoSource?
The register lists 1 active mandates at ImmunoSource. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ImmunoSource
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →